Evaluation of the Safety and Efficacy of Insulin Glargine + Glulisine or Insulin Regular + NPH Insulin (Isophane Insulin) Use in Type 2 Diabetes Mellitus Patients With Moderate Renal Failure.

NCT01122979 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: INSULIN GLARGINE
DRUG: NPH insulin (insulin isophane)
DRUG: INSULIN GLULISINE
DRUG: Regular insulin

Sponsor

Sanofi